ANAVEX LIFE SCIENCES CORP. short interest in 2026
In 2026, ANAVEX LIFE SCIENCES CORP.'s disclosed short interest ran from 22.15% of shares outstanding on 15 Jan 2026 to 15.46% on 15 Sep 2026, a change of -6.69 percentage points. The year's high was 23.74% on 13 Mar 2026 and its low 14.99% on 31 Aug 2026, averaging 19.67% across 17 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 25.13 days on 15 Sep 2026. Full history: ANAVEX LIFE SCIENCES CORP..
Cite this page
By year: 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2026 in figures
- Start of year
- 22.15% (15 Jan 2026)
- End of year
- 15.46% (15 Sep 2026)
- Change
- -6.69 pp
- High
- 23.74% (13 Mar 2026)
- Low
- 14.99% (31 Aug 2026)
- Average
- 19.67%
- Highest days to cover
- 25.13 (15 Sep 2026)
- SEC filings marked
- 5
Every report in 2026
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2026 | 22.15% | 12.28 | |
| 30 Jan 2026 | 22.33% | 16.19 | |
| 13 Feb 2026 | 22.98% | 13.17 | 10-Q filed, results (8-K) |
| 27 Feb 2026 | 22.79% | 21.58 | |
| 13 Mar 2026 | 23.74% | 21.27 | |
| 31 Mar 2026 | 21.56% | 6.95 | |
| 15 Apr 2026 | 21.21% | 17.17 | |
| 30 Apr 2026 | 21.28% | 22.76 | |
| 15 May 2026 | 21.53% | 19.62 | |
| 29 May 2026 | 21.08% | 16.63 | |
| 15 Jun 2026 | 19.62% | 15.23 | |
| 30 Jun 2026 | 15.93% | 6.87 | |
| 15 Jul 2026 | 15.83% | 15.60 | |
| 31 Jul 2026 | 16.15% | 14.43 | results (8-K) |
| 14 Aug 2026 | 15.79% | 14.31 | |
| 31 Aug 2026 | 14.99% | 16.66 | results (8-K), 10-Q filed |
| 15 Sep 2026 | 15.46% | 25.13 |
See also: ANAVEX LIFE SCIENCES CORP.'s full history · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.